Title: Comparison of Risperidone in Treatment for Comorbid of Depression and Anxiety
Abstract: OBJECTIVE To compare the efficacy and side effects of risperidone combined with fluoxetine on patients with comorbid of depression and anxiety.METHODS Eighty-six patients with comorbid of depression and anxiety were randomly divided into study group(risperidone+fluoxetine,n=44)and control group(fluoxetine,n=42)and observed for 8 weeks.All patients were assessed with HAMD-24,HAMA and TESS.RESULTS The significant difference in HAMD and HAMA from second weekend between two groups was found but no significant difference in TESS.CONCLUSION Risperidone combined with fluoxetine has better efficacy and safety in treatment for comorbid of depression and anxiety.
Publication Year: 2008
Publication Date: 2008-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot